IL1B and concussion: Further sub-analyses showed significantly elevated blood IL-1β levels in the mTBI population in the acute stages (< 7 days) and brought down the heterogeneity (SMD: 0.42 [95% CI: 0.10, 0.74] pg/mL) (p = 0.01, I2 = 40%) (Figure 5B).